These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36070938)
1. Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis. Sawamura M; Sawa N; Ikuma D; Oba Y; Yamanouchi M; Sekine A; Mizuno H; Hasegawa E; Suwabe T; Hoshino J; Kono K; Kinowaki K; Ohashi K; Ubara Y Intern Med; 2023 Apr; 62(7):1037-1041. PubMed ID: 36070938 [TBL] [Abstract][Full Text] [Related]
2. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834 [TBL] [Abstract][Full Text] [Related]
3. A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset. Yamada T; Itagaki F; Aratani S; Kawasaki S; Terada K; Mugishima K; Kashiwagi T; Shimizu A; Tsuruoka S CEN Case Rep; 2019 Nov; 8(4):301-307. PubMed ID: 31399881 [TBL] [Abstract][Full Text] [Related]
4. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F Lupus; 2006; 15(8):490-5. PubMed ID: 16942000 [TBL] [Abstract][Full Text] [Related]
5. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis. Kamijo Y; Hashimoto K; Takahashi K; Ehara T; Shigematsu H; Higuchi M Clin Nephrol; 2011 Aug; 76(2):136-43. PubMed ID: 21762646 [TBL] [Abstract][Full Text] [Related]
6. Long-term data on tacrolimus treatment in lupus nephritis. Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908 [TBL] [Abstract][Full Text] [Related]
7. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Chan TM; Li FK; Hao WK; Chan KW; Lui SL; Tang S; Lai KN Lupus; 1999; 8(7):545-51. PubMed ID: 10483033 [TBL] [Abstract][Full Text] [Related]
8. Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy. Espinoza LR; Jara LJ; Martinez-Osuna P; Silveira LH; Cuellar ML; Seleznick M Lupus; 1993 Feb; 2(1):9-14. PubMed ID: 8485564 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice. Ogawa H; Kameda H; Amano K; Takeuchi T Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069 [TBL] [Abstract][Full Text] [Related]
10. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis. Kronbichler A; Neumann I; Mayer G Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329 [TBL] [Abstract][Full Text] [Related]
11. Treatment of membranous lupus nephritis: where are we now? Beck LH; Salant DJ J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654 [TBL] [Abstract][Full Text] [Related]
13. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. Shapira Y; Mor F; Friedler A; Wysenbeek AJ; Weinberger A Ann Rheum Dis; 1990 Sep; 49(9):725-7. PubMed ID: 2241292 [TBL] [Abstract][Full Text] [Related]
14. Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus. Nakamura H; Fujieda Y; Yasuda S; Nakai M; Atsumi T Ann Intern Med; 2018 Sep; 169(5):352-353. PubMed ID: 29710334 [No Abstract] [Full Text] [Related]
15. Co-existing autosomal dominant polycystic kidney disease and nephrotic syndrome in a Nigerian patient with lupus nephritis. Akinbodewa AA; Adejumo OA; Ogunsemoyin AO; Osasan SA; Adefolalu OA Ann Afr Med; 2016; 15(2):83-6. PubMed ID: 27044732 [TBL] [Abstract][Full Text] [Related]
16. Tacrolimus Induction Therapy for Nephrotic Syndrome Caused by Minimal Mesangial Lupus Nephritis with Lupus Podocytopathy: A Case-Based Review. Kurihara I; Terai C; Yabe H; Sugawara H Am J Case Rep; 2022 Nov; 23():e937201. PubMed ID: 36336892 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. Fu LW; Yang LY; Chen WP; Lin CY Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080 [TBL] [Abstract][Full Text] [Related]
18. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis. Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077 [TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of lupus nephritis with cyclosporin A. Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761 [TBL] [Abstract][Full Text] [Related]
20. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis. Jesus D; Rodrigues M; da Silva JAP; Inês L Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]